دورية أكاديمية

The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counseling and newborn screening

التفاصيل البيبلوغرافية
العنوان: The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counseling and newborn screening
المؤلفون: Thauvin-Robinet, Christel, Munck, Anne, Huet, Frédéric, Génin, Emmanuelle, Bellis, Gil, Gautier, Elodie, Audrézet, Marie-Pierre, Férec, Claude, Lalau, Guy, Georges, Marie, Claustres, Mireille, Bienvenu, Thierry, Gérard, Bénédicte, Boisseau, Pierre, Cabet-Bey, Faiza, Feldmann, Delphine, Clavel, Christine, Bieth, Eric, Iron, Albert, Simon-Bouy, Brigitte, Costa, Catherine, Médina, Rachel, Leclerc, Julie, Hubert, Dominique, Nové-Josserand, Raphaële, Sermet-Gaudelus, Isabelle, Rault, Gilles, Flori, Jean, Leroy, Sylvie, Wizla, Nathalie, Bellon, Gabriel, Haloun, Alain, Pérez-Martin, Stéphanie, D'Acremont, Gwenaelle, Corvol, Harriet, Clément, Annick, Houssin, Elise, Binquet, Christine, Bonithon-Kopp, Claire, Alberti-Boulme, Corinne, Morris, Michael A, Faivre, Laurence, Goossens, Michel, Roussey, Michel, the collaborating working group, Girodon, Emmanuelle
بيانات النشر: British Medical Journal Publishing Group
سنة النشر: 2009
المجموعة: HighWire Press (Stanford University)
مصطلحات موضوعية: Letters to JMG
الوصف: Introduction: Cystic Fibrosis (CF) is caused by compound heterozygosity or homozygosity of CF transmembrane conductance regulator gene (CFTR) mutations. Phenotypic variability associated with certain mutations makes genetic counselling difficult, notably for R117H, whose disease-phenotype varies from asymptomatic to classical CF. The high frequency of R117H observed in CF newborn screening has also introduced diagnostic dilemmas. The aim of this study was to evaluate the disease penetrance for R117H in order to improve clinical practice. Methods: The phenotypes in all individuals identified in France as compound heterozygous for R117H and F508del, the most frequent CF mutation, were described. The allelic prevalences of R117H (pR117H), on either intron 8 T5 or T7 background, and F508del (pF508del) were determined in the French population, to permit an evaluation of the penetrance of CF for the [R117H]+[F508del] genotype. Results: Clinical details were documented for 184 [R117H]+[F508del] individuals, including 72 newborns. The disease-phenotype was predominantly mild; one child had classical CF, and three adults’ severe pulmonary symptoms. In 5245 healthy adults, pF508del was 1.06%, pR117H;T7 0.27% and pR117H;T5 <0.01%. The theoretical number of [R117H;T7]+[F508del] individuals in the French population was estimated at 3650, whereas only 112 were known with CF-related symptoms (3.1%). The penetrance of classical CF for [R117H;T7]+[F508del] was estimated at 0.03% and that of severe CF in adulthood at 0.06%. Discussion: These results suggest that R117H should be withdrawn from CF mutation panels used for screening programmes. The real impact of so-called disease mutations should be assessed before including them in newborn or preconceptional carrier screening programmes.
نوع الوثيقة: text
وصف الملف: text/html
اللغة: English
العلاقة: http://jmg.bmj.com/cgi/content/short/jmg.2009.067215v1Test; http://dx.doi.org/10.1136/jmg.2009.067215Test
DOI: 10.1136/jmg.2009.067215
الإتاحة: https://doi.org/10.1136/jmg.2009.067215Test
http://jmg.bmj.com/cgi/content/short/jmg.2009.067215v1Test
حقوق: Copyright (C) 2009, BMJ Publishing Group Ltd
رقم الانضمام: edsbas.B3F8FB90
قاعدة البيانات: BASE